Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism

S. K. Powell, N. Khan, C. L. Parker, R. J. Samulski, G. Matsushima, S. J. Gray, T. J. McCown

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

No adeno-associated virus (AAV) capsid has been described in the literature to exhibit a primary oligodendrocyte tropism when a constitutive promoter drives gene expression, which is a significant barrier for efficient in vivo oligodendrocyte gene transfer. The vast majority of AAV vectors, such as AAV1, 2, 5, 6, 8 or 9, exhibit a dominant neuronal tropism in the central nervous system. However, a novel AAV capsid (Olig001) generated using capsid shuffling and directed evolution was recovered after rat intravenous delivery and subsequent capsid clone rescue, which exhibited a >95% tropism for striatal oligodendrocytes after rat intracranial infusion where a constitutive promoter drove gene expression. Olig001 contains a chimeric mixture of AAV1, 2, 6, 8 and 9, but unlike these parental serotypes after intravenous administration Olig001 has very low affinity for peripheral organs, especially the liver. Furthermore, in mixed glial cell cultures, Olig001 exhibits a 9-fold greater binding when compared with AAV8. This novel oligodendrocyte-preferring AAV vector exhibits characteristics that are a marked departure from previously described AAV serotypes.

Original languageEnglish (US)
Pages (from-to)807-814
Number of pages8
JournalGene Therapy
Volume23
Issue number11
DOIs
StatePublished - Nov 1 2016

Fingerprint

Dependovirus
Tropism
Oligodendroglia
Capsid
Gene Expression
Corpus Striatum
Neuroglia
Intravenous Administration
Central Nervous System
Clone Cells
Cell Culture Techniques
Liver
Genes

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics

Cite this

Powell, S. K., Khan, N., Parker, C. L., Samulski, R. J., Matsushima, G., Gray, S. J., & McCown, T. J. (2016). Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism. Gene Therapy, 23(11), 807-814. https://doi.org/10.1038/gt.2016.62

Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism. / Powell, S. K.; Khan, N.; Parker, C. L.; Samulski, R. J.; Matsushima, G.; Gray, S. J.; McCown, T. J.

In: Gene Therapy, Vol. 23, No. 11, 01.11.2016, p. 807-814.

Research output: Contribution to journalArticle

Powell, SK, Khan, N, Parker, CL, Samulski, RJ, Matsushima, G, Gray, SJ & McCown, TJ 2016, 'Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism', Gene Therapy, vol. 23, no. 11, pp. 807-814. https://doi.org/10.1038/gt.2016.62
Powell, S. K. ; Khan, N. ; Parker, C. L. ; Samulski, R. J. ; Matsushima, G. ; Gray, S. J. ; McCown, T. J. / Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism. In: Gene Therapy. 2016 ; Vol. 23, No. 11. pp. 807-814.
@article{c3f5d8cc88834d828f18781a3a48fdb9,
title = "Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism",
abstract = "No adeno-associated virus (AAV) capsid has been described in the literature to exhibit a primary oligodendrocyte tropism when a constitutive promoter drives gene expression, which is a significant barrier for efficient in vivo oligodendrocyte gene transfer. The vast majority of AAV vectors, such as AAV1, 2, 5, 6, 8 or 9, exhibit a dominant neuronal tropism in the central nervous system. However, a novel AAV capsid (Olig001) generated using capsid shuffling and directed evolution was recovered after rat intravenous delivery and subsequent capsid clone rescue, which exhibited a >95{\%} tropism for striatal oligodendrocytes after rat intracranial infusion where a constitutive promoter drove gene expression. Olig001 contains a chimeric mixture of AAV1, 2, 6, 8 and 9, but unlike these parental serotypes after intravenous administration Olig001 has very low affinity for peripheral organs, especially the liver. Furthermore, in mixed glial cell cultures, Olig001 exhibits a 9-fold greater binding when compared with AAV8. This novel oligodendrocyte-preferring AAV vector exhibits characteristics that are a marked departure from previously described AAV serotypes.",
author = "Powell, {S. K.} and N. Khan and Parker, {C. L.} and Samulski, {R. J.} and G. Matsushima and Gray, {S. J.} and McCown, {T. J.}",
year = "2016",
month = "11",
day = "1",
doi = "10.1038/gt.2016.62",
language = "English (US)",
volume = "23",
pages = "807--814",
journal = "Gene Therapy",
issn = "0969-7128",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism

AU - Powell, S. K.

AU - Khan, N.

AU - Parker, C. L.

AU - Samulski, R. J.

AU - Matsushima, G.

AU - Gray, S. J.

AU - McCown, T. J.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - No adeno-associated virus (AAV) capsid has been described in the literature to exhibit a primary oligodendrocyte tropism when a constitutive promoter drives gene expression, which is a significant barrier for efficient in vivo oligodendrocyte gene transfer. The vast majority of AAV vectors, such as AAV1, 2, 5, 6, 8 or 9, exhibit a dominant neuronal tropism in the central nervous system. However, a novel AAV capsid (Olig001) generated using capsid shuffling and directed evolution was recovered after rat intravenous delivery and subsequent capsid clone rescue, which exhibited a >95% tropism for striatal oligodendrocytes after rat intracranial infusion where a constitutive promoter drove gene expression. Olig001 contains a chimeric mixture of AAV1, 2, 6, 8 and 9, but unlike these parental serotypes after intravenous administration Olig001 has very low affinity for peripheral organs, especially the liver. Furthermore, in mixed glial cell cultures, Olig001 exhibits a 9-fold greater binding when compared with AAV8. This novel oligodendrocyte-preferring AAV vector exhibits characteristics that are a marked departure from previously described AAV serotypes.

AB - No adeno-associated virus (AAV) capsid has been described in the literature to exhibit a primary oligodendrocyte tropism when a constitutive promoter drives gene expression, which is a significant barrier for efficient in vivo oligodendrocyte gene transfer. The vast majority of AAV vectors, such as AAV1, 2, 5, 6, 8 or 9, exhibit a dominant neuronal tropism in the central nervous system. However, a novel AAV capsid (Olig001) generated using capsid shuffling and directed evolution was recovered after rat intravenous delivery and subsequent capsid clone rescue, which exhibited a >95% tropism for striatal oligodendrocytes after rat intracranial infusion where a constitutive promoter drove gene expression. Olig001 contains a chimeric mixture of AAV1, 2, 6, 8 and 9, but unlike these parental serotypes after intravenous administration Olig001 has very low affinity for peripheral organs, especially the liver. Furthermore, in mixed glial cell cultures, Olig001 exhibits a 9-fold greater binding when compared with AAV8. This novel oligodendrocyte-preferring AAV vector exhibits characteristics that are a marked departure from previously described AAV serotypes.

UR - http://www.scopus.com/inward/record.url?scp=84988421378&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988421378&partnerID=8YFLogxK

U2 - 10.1038/gt.2016.62

DO - 10.1038/gt.2016.62

M3 - Article

C2 - 27628693

AN - SCOPUS:84988421378

VL - 23

SP - 807

EP - 814

JO - Gene Therapy

JF - Gene Therapy

SN - 0969-7128

IS - 11

ER -